SCHEMBL23749602

SCHEMBL23749602

O=C(Cl)C=Cc1cnc[nH]1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.70
TSHR P16473 2/20 0.70
KDM4E B2RXH2 2/20 0.70
BLM P54132 1/20 0.70
NPSR1 Q6W5P4 1/20 0.70
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
SMYD3 Q9H7B4 1/20 0.50
AOC1 P19801 2/20 0.47
ENPP2 Q13822 1/20 0.42
PADI4 Q9UM07 1/20 0.41
JAK3 P52333 1/20 0.38
HRH3 Q9Y5N1 3/20 0.37
ALDH1A1 P00352 3/20 0.36
GABRA1 P14867 1/20 0.36
NFKB1 P19838 1/20 0.36
GABRR1 P24046 1/20 0.36
GABRR2 P28476 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRB2 P47870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cis-Urocanic Acid SCHEMBL12963908 0.82 CYP3A4 (1.00) CYP3A4TSHRKDM4EBLMNPSR1
Cis-Urocanic Acid SCHEMBL1136889 0.82 CYP3A4 (1.00) CYP3A4TSHRKDM4EBLMNPSR1
SCHEMBL21334959 0.77 KMT2A (1.00) CYP3A4TSHRKDM4EBLMNPSR1
SCHEMBL25101013 0.77 KDM4E (0.64) CYP3A4TSHRKDM4EBLMNPSR1
SCHEMBL8552929 0.77 KMT2A (1.00) CYP3A4TSHRKDM4EBLMNPSR1
SCHEMBL2567149 0.73 MEN1 (0.69) CYP3A4TSHRKDM4EBLMNPSR1
SCHEMBL11598556 0.73 MEN1 (0.69) CYP3A4TSHRKDM4EBLMNPSR1
SCHEMBL13895761 0.73 CYP3A4 (0.58) CYP3A4TSHRKDM4EBLMNPSR1
SCHEMBL19176562 0.70 CYP3A4 (0.54) CYP3A4TSHRKDM4EBLMNPSR1
SCHEMBL12264488 0.70 CYP3A4 (0.54) CYP3A4TSHRKDM4EBLMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4103640-B1 NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF NOVOCHIZOL SA (CH) 2025-02-26 EP disclosed
US-20230096466-A1 NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF NOVOCHIZOL SA (CH) 2023-03-30 US disclosed
EP-3865535-A1 NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF Bosti Trading Ltd. (CY) 2021-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230096466-A1 NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF CHIA, CHIT1, CHI3L2 CYP3A4 4051/4885TSHR 4777/4885KDM4E 3075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.